You are here

biosimilars

Amneal scores third biosimilar approval in three months

Biopharma Reporter

Tue, 05/31/22 - 10:31 am

The patent winter is coming

EP Vantage

Wed, 05/25/22 - 10:41 am

Bristol Myers Squibb

J&J's crown jewel Stelara faces another potential rival as biosim player Alvotech touts trial win

Fierce Pharma

Tue, 05/24/22 - 04:31 pm

Teva Pharmaceutical

Could This Biosimilar Drug Candidate Create a Blockbuster for Amgen?

Motley Fool

Mon, 05/23/22 - 06:44 pm

Roche Wakes Up to New Competition as FDA Approves Amneal’s Avastin Biosimilar

BioSpace

Thu, 04/14/22 - 10:57 am

bevacizumab-maly

The mysterious case of Viatris and the missing insulin label deepens

Fierce Pharma

Wed, 04/13/22 - 10:42 am

product recalls

More biosimilar use could've saved Medicare and beneficiaries $84M in 2019, HHS OIG says

Endpoints

Sat, 04/2/22 - 11:46 am

Medicare Part D

Five things to watch as the Biosimilars market heats up in 2022

Pharmaforum

Fri, 04/1/22 - 10:40 am

Two US companies ink deals to expand biosimilar offerings

Endpoints

Thu, 03/17/22 - 11:29 pm

Biosimilars Solutions

Evio Pharmacy Solutions

AbbVie, Alvotech settle Humira patent and trade secrets disputes, teeing up another biosim rollout next year

Fierce Pharma

Wed, 03/9/22 - 10:46 am

FDA offers funding for biosimilar regulatory science pilot

RAPS.org

Mon, 03/7/22 - 10:54 pm

Biocon buys Viatris biosimilars for $3.3bn, eyes IPO

Pharmaforum

Mon, 02/28/22 - 09:20 am

Biogen to sell stake in Samsung Bioepis JV for up to $2.3bn

Biopharma Reporter

Fri, 01/28/22 - 10:07 am

Samsung Bioepis

Secondary patents prove to be key in biosimilar blocking strategies, researchers find

Endpoints

Wed, 01/19/22 - 11:21 pm

secondary patents

Prestige BioPharma and Dr. Reddy’s partner to sell trastuzumab biosimilar

Pharmaceutical Business Review

Thu, 12/9/21 - 10:57 am

Prestige BioPharma

Amgen stalls Samsung's Enbrel biosim until 2029 in 2nd patent win of the year

Fierce Pharma

Wed, 12/1/21 - 10:14 am

Spinoff updates: Merck’s Organon and Novartis’ Sandoz

Generics and Biosimilar Initiative

Mon, 11/29/21 - 11:08 pm

Amgen's Otezla, Repatha and biosimilars put on notice, with challenging years ahead

Fierce Pharma

Mon, 11/22/21 - 10:13 pm

Viatris launched two versions of its interchangeable insulin biosimilar. Why?

Fierce Pharma

Tue, 11/16/21 - 10:29 pm

Boehringer's interchangeable tag for Humira biosim is a 'landmark' win for the field: analyst

Fierce Pharma

Tue, 10/19/21 - 11:59 am

Boehringer Ingelheim

interchangeable biosimilars

Pages